Fierce Biotech Webinar: The ‘D’ in DCT stands for Decentralized

Decentralized trial (DCT) design has emerged in recent years and shaken up the clinical trial landscape. In an upcoming webinar on Tuesday, Jun 7^th, Dr. Graham Wylie of MRN will share his knowledge of clinical trial best practices to empower teams performing or considering DCTs. In the talk, Wylie will discuss how to ensure excellent patient care, benefit from clinical and eclinical solutions, and facilitate patient participation.

According to Fierce Biotech, “Dr Graham Wylie has worked in the pharmaceutical industry for over 30 years and has been an agent of change throughout.  His career started at Pfizer, spanning clinical trial management, development of global technology platforms and global change management and continued at PAREXEL as a Medical Director and then Vice President of Account Management.  He formed MRN as CEO in 2006, which has since become the market-leading Clinical Trial Support Organization in the field of international decentralized clinical trial delivery.”

To learn more, click here.

(Source: Fierce Biotech, May 26^th, 2022)